Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for HXL given its capital-intensive manufacturing model, significant debt financing, and shareholder return program that directly links earnings, cash flow, and balance sheet leverage.

Composite Trajectory: Mixed

The annual series through December 2025 shows clear deterioration: revenue flat, operating margin compressed for three consecutive years (12.0% → 9.8% → 9.1%), operating cash flow down 20% YoY, and net debt up 60% to $922M. The quarterly series through June 2026 shows a sharp inflection: H1 2026 revenue up 8.9% YoY, operating margin expanded to 12.6% from 7.8%, and operating cash flow swung to $96.7M from -$5.2M. These opposing directional signals across timeframes — annual deterioration vs. recent quarterly improvement — produce a mixed composite picture.

2. Red Flags

• Debt surge alongside cash drain in 2025: Total debt rose 42% to $993.0M while cash fell 43% to $71.0M, pushing net debt to $922.0M from ~$575M (10-K 2025-12-31, Consolidated Balance Sheets; MD&A Financial Condition)
• Three-year operating margin compression: 12.0% (2023) → 9.8% (2024) → 9.1% (2025) on roughly flat revenue (10-K 2025-12-31, Consolidated Statements of Operations)
• Operating cash flow dropped 20% YoY in 2025: $230.5M vs $289.9M despite only modest revenue decline (10-K 2025-12-31, Consolidated Statements of Cash Flows)
• Share repurchases funded by borrowing: $454.3M of buybacks in 2025 vs $252.2M in 2024 while total debt increased $292M; $350M ASR in Q4 2025 funded entirely by revolver draw (10-K 2025-12-31, Consolidated Statements of Cash Flows; MD&A Liquidity)
• Recurring "non-recurring" restructuring: Charges of $28.4M (2025), $2.3M (2024), $0.8M (2023) each labeled as restructuring (10-K 2025-12-31, Note 12 Restructuring)
• Wide and persistent GAAP/non-GAAP gap: Adjusted operating income exceeded GAAP by 22% ($209.4M vs $171.6M) in 2025 and 27% ($236.1M vs $186.1M) in 2024 (10-K 2025-12-31, Non-GAAP Financial Measures)
• Working capital build in Q2 2026: Accounts receivable up 20% ($299.2M vs $249.3M) and inventory up 5% ($345.2M vs $328.8M) sequentially while cash fell 12% (10-Q 2026-06-30, Consolidated Balance Sheets)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results deteriorated over three years: net sales essentially flat ($1,789M → $1,903M → $1,894M), gross margin fell from 24.2% to 24.7% to 23.0%, operating income declined from $215.3M to $186.1M to $171.6M, and diluted EPS fell from $1.24 to $1.59 to $1.37 (10-K 2025-12-31, Consolidated Statements of Operations). However, the most recent comparable quarterly periods show strong improvement: Q2 2026 revenue rose 8.0% YoY to $529.3M, operating margin expanded to 13.7% from 6.1%, and diluted EPS jumped to $0.64 from $0.17; H1 2026 revenue rose 8.9% to $1,030.8M with operating margin of 12.6% vs 7.8% (10-Q 2026-06-30, MD&A Results of Operations). The annual and quarterly series point in opposite directions.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow peaked in 2024 at $289.9M then fell 20% to $230.5M in 2025, below the 2023 level of $257.1M; free cash flow (non-GAAP) followed a similar pattern: $148.9M (2023, derived) → $202.9M (2024) → $157.2M (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows; Non-GAAP Financial Measures). Capital expenditures declined each year ($108.2M → $87.0M → $73.3M). In contrast, H1 2026 operating cash flow surged to $96.7M from -$5.2M in H1 2025, driven by higher net income and lower working capital cash use ($72.2M use vs $124.5M use) (10-Q 2026-06-30, MD&A Operating Activities). The annual trend is weakening; the recent half-year shows a sharp reversal.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

The annual balance sheet weakened markedly in 2025: total debt rose 42% to $993.0M from $700.7M, cash fell 43% to $71.0M from $125.4M, net debt climbed to $922M, and total equity dropped 18% to $1,250.7M from $1,527.9M largely due to $454.3M of share repurchases (10-K 2025-12-31, Consolidated Balance Sheets; Consolidated Statements of Cash Flows). The Q2 2026 snapshot shows modest debt reduction to $959.4M but cash declined further to $62.2M, while accounts receivable and inventories grew 20% and 5% respectively, indicating working capital pressure (10-Q 2026-06-30, Consolidated Balance Sheets). Leverage increased substantially in 2025 and remains elevated with no meaningful deleveraging evident through June 2026.

6. Data Gaps

• Full-year 2026 results (10-K not yet filed)
• Q3 2026 and Q4 2026 quarterly reports (10-Qs not yet filed)
• Q1 2026 standalone quarterly balance sheet and cash flow (only H1 and Q2 2026 provided)
• Quarterly free cash flow (H1 2026 capex $44.9M disclosed but quarterly breakdown not provided)
• Segment-level cash flow statements (only consolidated provided)
• 2026 debt maturity schedule post-refinancing (only narrative "2031" mentioned in 10-Q)